These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22562275

  • 1. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
    Szmidt M.
    Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
    [Abstract] [Full Text] [Related]

  • 2. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 3. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ, Keating GM.
    Treat Respir Med; 2004 Aug; 3(4):247-68. PubMed ID: 15350163
    [Abstract] [Full Text] [Related]

  • 4. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
    Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R.
    Am J Respir Crit Care Med; 2009 Oct 15; 180(8):741-50. PubMed ID: 19644045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S, Eberlein M, Eckhoff J, Schirren J.
    Eur J Cardiothorac Surg; 2011 Jun 15; 39(6):995-1000. PubMed ID: 20970351
    [Abstract] [Full Text] [Related]

  • 8. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K.
    Respir Med; 2008 Apr 15; 102(4):479-87. PubMed ID: 18258423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC, Reis M, Siqueira AC, Barroco AC, Takara LS, Bravo DM, Andreoni S, Neder JA.
    Respir Med; 2010 Sep 15; 104(9):1288-96. PubMed ID: 20580216
    [Abstract] [Full Text] [Related]

  • 11. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M, Noschese P, Salzillo A, De Giglio C, D'Amato G, Matera MG.
    Respir Med; 2005 May 15; 99(5):524-8. PubMed ID: 15823447
    [Abstract] [Full Text] [Related]

  • 12. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF, Timmer W, Sagkriotis A, Viel K.
    Chest; 2008 Aug 15; 134(2):255-262. PubMed ID: 18403672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study.
    Di Marco F, Verga M, Santus P, Morelli N, Cazzola M, Centanni S.
    Respir Med; 2006 Nov 15; 100(11):1925-32. PubMed ID: 16626956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I.
    Adv Ther; 2009 Nov 15; 26(11):1024-34. PubMed ID: 19953349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.